SunTrust Banks Inc. began coverage on shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) in a research report issued to clients and investors on Thursday, The Fly reports. The brokerage set a “buy” rating on the stock.

A number of other equities analysts have also commented on EKSO. Zacks Investment Research lowered Ekso Bionics Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, July 13th. Rodman & Renshaw restated a “buy” rating on shares of Ekso Bionics Holdings in a research note on Sunday, July 31st. Finally, B. Riley started coverage on Ekso Bionics Holdings in a research note on Thursday, September 15th. They set a “buy” rating and a $8.00 price objective on the stock.

Ekso Bionics Holdings (NASDAQ:EKSO) traded down 2.58% during midday trading on Thursday, hitting $6.05. The stock had a trading volume of 390,403 shares. Ekso Bionics Holdings has a 52 week low of $3.45 and a 52 week high of $10.08. The company’s 50-day moving average price is $4.31 and its 200 day moving average price is $5.40. The company’s market capitalization is $99.41 million.

Ekso Bionics Holdings (NASDAQ:EKSO) last posted its quarterly earnings data on Thursday, July 28th. The company reported ($0.61) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.28) by $0.33. On average, analysts expect that Ekso Bionics Holdings will post ($1.74) EPS for the current year.

5 Day Chart for NASDAQ:EKSO

The Fly

Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with's FREE daily email newsletter.